Morphic Holding, Inc. (MORF) financial statements (2022 and earlier)

Company profile

Business Address 35 GATEHOUSE DRIVE A2
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments171,434228,264237,016
Cash and cash equivalents171,434102,047101,559
Short-term investments 126,217135,457
Receivables2,3077,3143,467
Other undisclosed current assets244,5933,8573,090
Total current assets:418,334239,435243,573
Noncurrent Assets
Operating lease, right-of-use asset4,806  
Property, plant and equipment2,5832,6063,446
Other noncurrent assets766141
Other undisclosed noncurrent assets560275275
Total noncurrent assets:7,9562,9473,862
TOTAL ASSETS:426,290242,382247,435
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:12,83810,1606,639
Accounts payable4,7983,845 
Accrued liabilities9636771,015
Employee-related liabilities6,3965,1483,159
Other undisclosed accounts payable and accrued liabilities6814902,465
Deferred revenue20,62825,26623,450
Deferred rent credit 16794
Other undisclosed current liabilities4,7983,8455,167
Total current liabilities:38,26439,43835,350
Noncurrent Liabilities
Long-term debt and lease obligation3,838  
Operating lease, liability3,838  
Liabilities, other than long-term debt47,48957,74771,167
Deferred revenue47,48957,67270,954
Deferred rent credit 75213
Total noncurrent liabilities:51,32757,74771,167
Total liabilities:89,59197,185106,517
Stockholders' equity
Stockholders' equity attributable to parent336,699145,197140,918
Common stock433
Additional paid in capital575,231287,727238,384
Accumulated other comprehensive income (loss)(482)(21)44
Accumulated deficit(238,054)(142,512)(97,513)
Total stockholders' equity:336,699145,197140,918
TOTAL LIABILITIES AND EQUITY:426,290242,382247,435

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
Revenues19,79444,94516,977
Gross profit:19,79444,94516,977
Operating expenses(115,600)(92,125)(63,965)
Operating loss:(95,806)(47,180)(46,988)
Nonoperating income2641,6114,572
Other nonoperating income (expense)(8)1,6114,572
Loss from continuing operations before income taxes:(95,542)(45,569)(42,416)
Income tax expense (benefit) 570(912)
Net loss available to common stockholders, diluted:(95,542)(44,999)(43,328)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
Net loss:(95,542)(44,999)(43,328)
Other comprehensive income (loss)(461)(65)44
Comprehensive loss, net of tax, attributable to parent:(96,003)(45,064)(43,284)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: